Stock VERMILLION INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar VERMILLION INC Nasdaq

Equities

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for VERMILLION INC
07-09 Aspira Women's Health Inc. announced that it has received $1.910249 million in funding CI
07-02 Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Powell Speech MT

Chart calendar VERMILLION INC

d705f8add.iJOcNvDKRUJ5NdA8jL136GFLN4yj5KmovxODuBH83WQ.pcqsQ8OCPRAKfrx97c8wmgdyVOfHr5rJzUXv8Um4kVel9Mhhx68IdCgH6A~ec9c2f1a9928c51ae3c497d762db68d9

Upcoming events on VERMILLION INC

07/08/2024 Q2 2024 Earnings Release (Projected)
12/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)
13/05/2025 Q1 2025 Earnings Release (Projected)

Past events on VERMILLION INC

21/05/2024 19:00 Alliance Global Partners Healthcare Showcase
15/05/2024 13:30 Q1 2024 Earnings Call
15/05/2024 12:30 Q1 2024 Earnings Release
13/05/2024 17:00 Annual General Meeting
13/04/2024 US Association for the Study of Pain Conference
11/04/2024 William A. Little University OBGYN Alumni Society Conference
03/04/2024 21:20 MedInvest Biotech & Pharma Investor Conference
28/03/2024 12:30 Q4 2023 Earnings Call
28/03/2024 11:30 Q4 2023 Earnings Release
18/03/2024 California Association for Nurse Practitioners Conference
15/03/2024 16:00 Society for Reproductive Investigation Scientific Meeting - Abstract No - 2066
01/03/2024 15:30 Cancer Advocacy Group of Louisiana NeauxCancer Conference
30/01/2024 17:45 Water Tower Research
29/01/2024 The DealFlow Microcap Conference
09/01/2024 Investor Meeting - H.C. Wainwright & Co
07/01/2024 LifeSci Partners Corporate Access Event
04/01/2024 16:00 R&D Day
13/11/2023 21:30 Q3 2023 Earnings Call
13/11/2023 21:05 Q3 2023 Earnings Release
06/10/2023 00:30 BioVenture Nexus Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


4,65
4,50
3.36%		6,81
6,80
0.18%		8,18
8,25
-0.8%		9,15
9,58
-4.41%
10,9

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00


-18,0
-16,3
-10.03%		0,00
0,00
- 		-32,8
-35,3
7.11%		-18,9
-18,4
-2.21%
-17,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-17,9
-16,3
-9.84%		0,00
0,00
- 		-27,2
-32,7
16.97%		-16,7
-17,7
5.71%
-16,9

Net income
Million USD		Released
Forecast
Spread 		-15,2


-17,9
-16,3
-9.84%		0,00
0,00
- 		-27,2
-32,7
16.97%		-16,7
-17,6
5.08%
-17,1

EPS
USD		Released
Forecast
Spread 		-2,70


-2,70
-2,40
-12.5%		-4,20
-4,50
6.67%		-3,45
-4,28
19.3%		-1,81
-1,92
5.73%
-1,30

Announcement Date26/03/2025/03/2123/03/2222/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		1,89
1,96
-3.3%


2,07
2,40
-13.67%		2,15
2,25
-4.31%		2,32
2,55
-9.18%		2,49
2,80
-11.04%		2,22
2,90
-23.55%		2,13
2,55
-16.47%		2,15
2,58
-16.45%
2,60


2,90


3,19


4,00


4,70

EBIT
Million USD		Released
Forecast
Spread 		-9,25
-8,60
-7.52%


-9,70
-7,80
-24.32%		-5,60
-8,60
34.87%		-5,77
-5,40
-6.83%		-4,32
-4,91
12.01%		-4,12
-4,95
16.79%		-4,14
-4,28
3.31%		-4,71
-4,24
-10.96%
-4,18


-4,40


-4,44







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,27
-8,60
-7.77%


-4,56
-7,80
41.56%		-5,10
-8,60
40.69%		-6,07
-5,40
-12.35%		-2,32
-4,30
46.12%		-4,71
-4,65
-1.2%		-3,09
-4,65
33.57%		-4,63
-4,00
-15.73%
-4,00


-4,20


-4,10







Net income
Million USD		Released
Forecast
Spread 		-9,27
-8,60
-7.77%		-8,24


-4,56
-7,80
41.56%		-5,10
-8,60
40.69%		-6,07
-5,40
-12.35%		-2,32
-4,91
52.82%		-4,71
-4,95
4.86%		-3,09
-4,64
33.47%		-4,63
-4,20
-10.26%
-4,00


-4,20


-4,10







EPS
USD		Released
Forecast
Spread 		-1,20
-1,20
0%		-1,05


-0,60
-1,05
42.86%		-0,60
-0,98
38.46%		-0,73
-0,75
2.67%		-0,28
-0,55
48.78%		-0,48
-0,51
5.42%		-0,30
-0,45
32.58%		-0,39
-0,33
-17.29%
-0,31


-0,27


-0,24


-0,23


-0,22

Announcement Date11/05/2210/08/2210/11/2222/03/2315/05/2314/08/2313/11/2328/03/2415/05/24-----

Upcoming sector events for VERMILLION INC

29/07/2024 VERACYTE, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 21:05 EXACT SCIENCES CORPORATION: Q2 2024 Earnings Release
31/07/2024 CAREDX, INC: Q2 2024 Earnings Release (Projected)
31/07/2024 IOVANCE BIOTHERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 GUARDANT HEALTH, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 ADAPTIVE BIOTECHNOLOGIES CORPORATION: Q2 2024 Earnings Release
06/08/2024 MARAVAI LIFESCIENCES HOLDINGS, INC.: Q2 2024 Earnings Release
13/08/2024 SEEGENE, INC.: Q2 2024 Earnings Release (Projected)
23/08/2024 BGI GENOMICS CO., LTD.: Q2 2024 Earnings Release
27/10/2024 BGI GENOMICS CO., LTD.: Q3 2024 Earnings Release (Projected)
More events

Past sector events for VERMILLION INC

09/05/2024 SEEGENE, INC.: Q1 2024 Earnings Release
09/05/2024 21:05 GUARDANT HEALTH, INC.: Q1 2024 Earnings Release
09/05/2024 21:01 IOVANCE BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
08/05/2024 21:05 MARAVAI LIFESCIENCES HOLDINGS, INC.: Q1 2024 Earnings Release
08/05/2024 21:05 EXACT SCIENCES CORPORATION: Q1 2024 Earnings Release
07/05/2024 21:05 VERACYTE, INC.: Q1 2024 Earnings Release
26/04/2024 BGI GENOMICS CO., LTD.: Q1 2024 Earnings Release
12/04/2024 BGI GENOMICS CO., LTD.: Q4 2023 Earnings Release
28/02/2024 21:05 CAREDX, INC: Q4 2023 Earnings Release
28/02/2024 21:01 IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release
  1. Stock Market
  2. Equities
  3. AWH Stock
  4. Stock
  5. Calendar VERMILLION INC